AbbVie abandons late-stage lung cancer asset Rova-T - Physician's Weekly
AbbVie abandons late-stage lung cancer asset Rova-T Physician's Weekly
Aug 29, 2019 | Reuters | 0 |. AbbVie abandons late-stage lung cancer asset Rova-T. (Reuters) – AbbVie Inc said on Thursday it will cease to develop its ...
Comments
Post a Comment